-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297

Benzinga·11/04/2026 19:00:03
Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $271 to $297.